10.1007/s40097-020-00333-1

Sonosynthesis and characterization of a fluorescent Trojan Horse based on magnetic nanoparticles

  • Dolores Reyman*1,
  • Marina Pérez-Ramos1,
  • Cristina Díaz-Oliva1,
  1. Departamento de Química Física Aplicada, Universidad Autónoma de Madrid, Ciudad Universitaria de Cantoblanco, Madrid, 28049, ES

Published in Issue 20-02-2020

How to Cite

Reyman, D., Pérez-Ramos, M., & Díaz-Oliva, C. (2020). Sonosynthesis and characterization of a fluorescent Trojan Horse based on magnetic nanoparticles. Journal of Nanostructure in Chemistry, 10(2 (June 2020). https://doi.org/10.1007/s40097-020-00333-1
Crossref
Scopus
Google Scholar
Europe PMC

Abstract

Abstract In this work, the sonosynthesis of a fluorescent nanocarrier based on iron oxide nanoparticles (mainly magnetite) conjugated with cisplatin, ethylene glycol (EG) and folic acid (FA) is presented. A spectroscopic study on the formation of a complex Fe(II)–FA was performed with the aim of evaluating how the adsorption of FA onto the magnetite takes place. The magnetite ferrofluids were characterized by Raman microspectroscopy, Transmission electron microscopy (TEM), UV–Vis spectroscopy (absorbance and fluorescence), X-ray fluorescence (TXRF) and X-ray diffraction (XRD). The structural analysis shows that Pt is part of the crystal structure of the system together with magnetite. The study also demonstrates that the cisplatin–folate interaction results in a less stable ferrofluid than that obtained in the absence of Pt. However, unlike the latter, the former shows fluorescence. Graphic abstract Magnetic and fluorescent Trojan Horse containing platinum

Keywords

  • Sonosynthesis,
  • Magnetic nanoparticle,
  • Magnetite,
  • Ethylene glycol,
  • UV–Vis spectroscopy of folate and cisplatin

References

  1. Valentine (2020) Toxic peripheral neuropathies: agents and mechanisms (pp. 152-173)
  2. De Luca et al. (2019) A structure-based mechanism of cisplatin resistance mediated by glutathione transferase P1-1 (pp. 13943-13951)
  3. Browning et al. (2017) Drug delivery strategies for platinum-based chemotherapy (pp. 8560-8578)
  4. Kim et al. (2015) Polymer biomaterials for the delivery of platinum-based anticancer drugs (pp. 1002-1017)
  5. He, Y., Cong, C., Liu, Z., Li, X., Zhu, R., Gao, D.: Stealth surface driven accumulation of “Trojan Horse” for tumor hypoxia relief in combination with targeted cancer therapy. Chem. Eng. J.
  6. 378
  7. , (2019)
  8. (UNSP 122252)
  9. Samadian et al. (2016) Folate-conjugated gold nanoparticle as a new nanoplatform for targeted cancer therapy (pp. 2217-2229)
  10. Zwicke et al. (2012) Utilizing the folate receptor for active targeting of cancer nanotherapeutics
  11. Shreffler et al. (2019) Overcoming hurdies in nanoparticle clinical translation: the influence of experimental design and surface modification
  12. Zhang et al. (2014) Cisplatin-loaded polymer/magnetite composite nanoparticles as multifunctional therapeutic nanomedicine (pp. 1329-1337)
  13. Blanco et al. (2015) Principles of nanoparticle design for overcoming biological barriers to drug delivery (pp. 941-951)
  14. Durymanov et al. (2015) Current approaches for improving intratumoral accumulation and distribution of nanomedicines (pp. 1007-1020)
  15. Couvreur et al. (2006) Nanotechnologies for drug delivery: application to cancer and autoimmune diseases (pp. 231-235)
  16. Bahrami et al. (2015) Folate-conjugated nanoparticles as a potent therapeutic approach in targeted cancer therapy (pp. 5727-5742)
  17. Vishwasrao et al. (2016) Luteinizing hormone releasing hormone-targeted cisplatin-loaded magnetite nanoclusters for simultaneous MR imaging ad chemotherapy of ovarian cancer (pp. 3024-3040)
  18. Peng et al. (2011) Targeted delivery of cisplatin to lung cancer using ScFvEGFR-heparin-cisplatin nanoparticles (pp. 9480-9493)
  19. Guan et al. (2019) Recognition sites for cancer-targeting drug delivery systems (pp. 815-834)
  20. Guo et al. (2011) Multifunctional superparamagnetic nanocarriers with folate-mediated and pH-responsive targeting properties for anticancer drug delivery (pp. 185-194)
  21. Cheon and Lee (2008) Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology (pp. 1630-1640)
  22. Nedyalkova et al. (2017) Iron oxide nanoparticles in vivo/in vitro biomedical applications and in silico studies (pp. 192-212)
  23. Adimoolam et al. (2018) A simple approach to design chitosan functionalized Fe3O4 nanoparticles for pH responsive delivery of doxorubicin for cancer therapy (pp. 199-207)
  24. Dung et al. (2009) Structural and magnetic properties of starch-coated magnetite nanoparticles (pp. 259-267)
  25. Hauser et al. (2015) The effects of synthesis method on the physical and chemical properties of dextran coated iron oxide nanoparticles (pp. 177-186)
  26. Zhang et al. (2013) Superparamagnetic iron oxide nanoparticles prepared by using an improved polyol method (pp. 375-379)
  27. Mahmoudi et al. (2008) Optimal design and characterization of superparamagnetic from oxide nanoparticles coated with polyvinyl alcohol for targeted delivery and imaging (pp. 14470-14481)
  28. Aliakbari et al. (2015) Influence of different synthesis conditions on properties of oleic acid-coated Fe3O4 nanoparticles (pp. 100-106)
  29. Avivi et al. (2001) The preparation of magnetic proteinaceous microspheres using the sonochemical method (pp. 123-129)
  30. Gonzalez-Moragas et al. (2015) Protective effects of bovine serum albumin on superparamagnetic iron oxide nanoparticles evaluated in the nematode caenorhabditis elegans (pp. 1129-1138)
  31. Li et al. (2008) Kinetics of adsorption of Saccharomyces cerevisiae mandelated dehydrogenase on magnetic Fe3O4-chitosan nanoparticles (pp. 11-18)
  32. Muzio et al. (2017) Innovative superparamagnetic iron-oxide nanoparticles coated with silica and conjugated with linoleic acid: effect on tumor cell growth and viability (pp. 439-447)
  33. Gole et al. (2008) Iron oxide coated gold nanorods: synthesis, characterization, and magnetic manipulation (pp. 6232-6237)
  34. Huang et al. (2007) Synthesis of high loading and encapsulation efficient paclitaxel-loaded poly(n-butylcyanoacrylate) nanoparticles via miniemulsion (pp. 267-275)
  35. Ankamwar et al. (2010) Biocompatibility of Fe3O4 nanoparticles evaluated by in vitro cytotoxicity assays using normal, glia and breast cancer cells (pp. 1-9)
  36. Shao et al. (2005) Control of iron nanoparticles size and shape by thermal decomposition method (pp. 3388-3390)
  37. Pei et al. (2005) Controlled monodisperse Fe nanoparticles synthesized by chemical method (pp. 3391-3393)
  38. Chin et al. (2011) Green synthesis of magnetite nanoparticles (via thermal decomposition method) with controllable size and shape (pp. 299-302)
  39. Campelj et al. (2008) Preparation and properties of water-based magnetic fluids (pp. 1-5)
  40. Alibeigi and Vaezi (2008) Phase Transformation of Iron Oxide Nanoparticles by Varying the Molar Ratio of Fe2+:Fe3+ (pp. 1591-1596)
  41. Dang et al. (2009) Sonochemical synthesis of monodispersed magnetite nanoparticles by using an ethanol-water mixed solvent (pp. 649-654)
  42. Ursachi et al. (2011) Magnetic properties of magnetite nanoparticles coated with mesorous silica by sonochemical method (pp. 2468-2473)
  43. Wang et al. (2015) Sonochemical synthesis of magnetic nanoparticles (pp. 616-621)
  44. Zhao et al. (2012) Preparation and magnetic properties of magnetite nanoparticles (pp. 112-114)
  45. Aliramaji et al. (2015) Characterization and synthesis of magnetite nanoparticles by innovative sonochemical method (pp. 265-269)
  46. Shafi et al. (2001) Sonochemical synthesis of functionalized amorphous iron oxide nanoparticles (pp. 5093-5097)
  47. Lin et al. (2009) Synthesis and characterization of magnetic nanoparticles embedded in polyvinyl pyrrolidone nanofiber film by electrospinning method (pp. 1-3)
  48. Mutahoosamy and Manickam (2017) State of the art and recent advances in the ultrasound-assisted synthesis, exfoliation and functionalization of graphene derivatives (pp. 478-493)
  49. Marchegiani et al. (2012) Sonochemical synthesis of versatile hydrophilic magnetite nanoparticles (pp. 877-882)
  50. Reyman et al. (2015) Sonochemical synthesis of iron oxide nanoparticles loaded with folate and cisplatin: effect of ultrasonic frequency (pp. 391-398)
  51. Slavov et al. (2010) Raman spectroscopy investigation of magnetite nanoparticles in ferrofluids (pp. 1904-1911)
  52. Andrade et al. (2010) pH Effect on the synthesis of magnetite nanoparticles by the chemical reduction-precipitation method (pp. 524-527)
  53. Thiéry (1973) Étude spectroscopique de l’acide folique (pp. 100-108)
  54. Fazary (2013) Ionic strength dependence of four stepwise protonation constants for folic acid in different aqueous solutions of dioxane (pp. 2219-2223)
  55. Daou et al. (2006) Hydrothermal synthesis of monodisperse magnetite nanoparticles (pp. 4399-4404)
  56. Chourpa et al. (2005) Molecular composition of iron oxide nanoparticles, precursors for magnetic drug targeting, as characterized by confocal Raman microspectroscopy (pp. 1395-1403)
  57. Oblonsky and Devine (1995) A surface enhanced Raman Spectroscopic study of the passive films formed in borate buffer on iron, nickel, chromium and stainless steel (pp. 17-41)
  58. Rotcharin et al. (2019) Simple continuous flow synthesis of linoleic and palmitic acid-coated magnetite nanoparticles
  59. Kim et al. (2012) A new method for the identification and quantification of magnetite-maghemite mixture using conventional X-ray diffraction technicque (pp. 348-352)